Results 301 to 310 of about 130,828 (352)

Impact of platelet transfusion refractoriness in the first 30 days post-hematopoietic stem cell transplantation on outcomes of patients with myelodysplastic syndrome. [PDF]

Front Immunol
Zhang Y, Wang Y, Ma R, Liu L, Sun J, Chen X, Yang D, Pang A, Zhang R, Ma Q, Zhai W, He Y, Wei J, Zhang T, Jiang E, Han M, Feng S.   +16 more
europepmc   +1 more source

[Platelet transfusion].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1970
openaire   +3 more sources

Platelet Transfusion and Death or Neurodevelopmental Impairment in Children Born Extremely Preterm.

JAMA Netw Open
Davenport PE, Wood TR, Heagerty PJ, Sola-Visner MC, Juul SE, Patel RM.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet Transfusion Therapy

Hematology/Oncology Clinics of North America, 2013
Platelet transfusion therapy has become an integral part of the treatment of patients with hematological and solid tumor malignancy receiving chemotherapy. Since its introduction almost 60 years ago, several advances and refinements have been introduced in the collection, storage, and administration to improve the safety and efficacy of platelet ...
Perumal, Thiagarajan, Vahid, Afshar-Kharghan   +1 more
openaire   +2 more sources

Canine platelet transfusions

Journal of Veterinary Emergency and Critical Care, 2009
AbstractObjective –To review potential platelet storage options, guidelines for administration of platelets, and adverse events associated with platelet transfusions.Data Sources –Data sources included original research publications and scientific reviews.Human Data Synthesis –Transfusion of platelet concentrates (PCs) plays a key role in the ...
Mary Beth, Callan, Elizabeth H, Appleman, Bruce S, Sachais   +2 more
openaire   +2 more sources

Optimizing platelet transfusions

Current Opinion in Hematology, 2015
Platelet transfusion remains a challenging procedure. Concerns about bacterial contamination and other complications, and the interest in improving the evidence base for criteria for platelet transfusion thresholds and policies have provided impetus for studies that challenge the status quo.
Kyle, Annen, Jordan E, Olson
openaire   +2 more sources

Prophylactic Platelet Transfusion

New England Journal of Medicine, 2013
To the Editor: We recently reported on a trial1 that was similar to the Trial of Prophylactic Platelets (TOPPS) by Stanworth et al. (May 9 issue).2 TOPPS showed that a strategy of prophylactic platelet transfusion, as compared with a strategy of no prophylaxis, was marginally superior in preventing bleeding of World Health Organization (WHO) grade 2 or
Hannes, Wandt, Kerstin, Schäfer-Eckart, Gerhard, Ehninger   +2 more
openaire   +3 more sources

Platelet Transfusion Therapy

Clinics in Laboratory Medicine, 1996
Although platelet transfusion is a vital part of modern hemotherapy, many related issues are unresolved. The most appropriate trigger point of transfusion and the clinical utility of prophylactic transfusion are still debated, but the importance of patient-specific transfusion decisions is clear.
openaire   +2 more sources

Platelet transfusion therapy

Journal of Clinical Apheresis, 2001
AbstractThe relative merits of apheresis platelets and platelet concentrates are undergoing debate due to evolving issues of safety, inventory, and cost. The application of photochemical inactivation technology may eliminate any rationale for the use of apheresis platelets rather than pooled platelet concentrates, so that the relative merits of these ...
openaire   +2 more sources